Keith Alan Self Periodic Transaction Report

Filed Oct 14, 2025 · House Clerk · 1 transaction

U.S. Representative · R · TX-03 · All trades by Keith Alan Self

On October 14, 2025, Rep. Keith Alan Self (R-TX-03) filed a periodic transaction report with the House Clerk disclosing 1 transaction (1 sale) dated Oct 7, 2025.

The filing covers 1 ticker, including $LDOS.

Reported amount ranges sum to $15K–$50K. Congress reports trade sizes in ranges, not exact figures.

Every trade was reported within the STOCK Act's 45-day window. The longest lag in this filing was 7 days.

Source document: House Clerk filing 9115686

Sample · the intelligence layer

Coldpine signal scoreA 0-1 composite from four weighted factors: disclosure speed, trade size, cluster activity (multiple members buying the same name), and the member’s track record. ≥ 0.65 is the high-conviction tier; ≥ 0.50 is moderate. Trades from trust-managed members are penalized (× 0.2 multiplier). It’s research, not a recommendation.

Keith Alan Self · Sold $LDOS · Oct 7 · $15K–$50K

0.46LOW

Disclosure speedx 0.250.60

Trade sizex 0.250.50

Cluster activityx 0.150.00

Track recordx 0.350.52

Every disclosed trade in the database gets this treatment: a four-factor score and a written read from Coldpine’s AI-based analysis. Informational only, not investment advice. Create a free account for every scored trade →

Follow Keith Alan Self

Get an email the moment Keith Alan Self files the next one. Free, no card, no spam.

Follow free →

Transactions

0 / 1

Buys / sells

Tickers

Longest lag

Tickers in this filing

LDOS1

Transactions disclosed

Trade date	Ticker	Asset	Type	Owner	Amount	Lag
Oct 7, 2025	LDOS	Leidos Holdings, Inc. Common Stock	sell	Self	$15K–$50K	7d

Other recent filings by Keith Alan Self

PTR filed Jun 30, 20265 trades · GPC, MRK, NVDA, PEP
PTR filed Jan 23, 20255 trades · MRK, NVDA, PEP, T

← All congressional filings, newest first

From Coldpine Research

Data parsed from the public STOCK Act filing linked above. Coldpine is a publisher of intelligence on congressional disclosures, not an investment adviser. Nothing here is a recommendation. See scores and Coldpine's read on every trade, free with an account →